biosimilars

Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
Fierce Pharma
Thu, 06/1/23 - 06:35 pm
Novartis
biosimilars
spinoffs
headquarters
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
JNJ
Amgen
patents
Stelara
biosimilars
legal
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Tue, 05/16/23 - 12:12 pm
Novartis
Sandoz
biosimilars
generics
women executives
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Fierce Pharma
Wed, 05/10/23 - 10:00 am
Novartis
Sandoz
Evotec
biosimilars
As Humira biosims take hold, longtime AbbVie CEO Richard Gonzalez talks succession plans
Fierce Pharma
Thu, 04/27/23 - 11:02 pm
AbbVie
Pharma CEOs
Richard Gonzalez
Humira
biosimilars
Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA
Business Insider
Mon, 04/17/23 - 11:06 pm
Teva Pharmaceutical
Alvotech
AVT02
FDA
Humira
biosimilars
FDA rejects Teva’s high-potency biosimilar of Humira again
Pharmaphorum
Fri, 04/14/23 - 10:37 am
Teva Pharmaceutical
Alvotech
biosimilars
FDA
Humira
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Wed, 03/29/23 - 03:56 pm
Amgen
JNJ
Stelara
psoriasis
patents
biosimilars
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
Endpoints
Mon, 03/20/23 - 09:50 am
JNJ
legal
Remicade
antitrust
biosimilars
Sandoz, betting on biosimilar sales, to build new production plant
BioPharma Dive
Thu, 03/9/23 - 09:15 pm
Sandoz
Novartis
drug manufacturing
Slovenia
biosimilars
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
Fri, 03/3/23 - 11:56 am
JNJ
patents
Janssen
Amgen
biosimilars
Stelara
Could This Humira Biosimilar Be a Winner for Amgen?
Motley Fool
Fri, 03/3/23 - 11:48 am
Amgen
biosimilars
Amjevita
Humira
Doctors largely comfortable with biosimilar drugs, but question economics: report
BioPharma Dive
Wed, 02/22/23 - 06:49 pm
Cardinal Health
physicians
biosimilars
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Tue, 02/21/23 - 11:05 am
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Pharmaceutical Business Review
Fri, 02/17/23 - 09:44 am
Fresenius Kabi
Stimufend
pegfilgrastim
biosimilars
Neulasta
Amgen
cancer
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
Thu, 02/16/23 - 04:49 pm
biosimilars
PBMs
physicians
AbbVie
Humira
Amgen
Amjevita
FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks
Endpoints
Mon, 02/13/23 - 10:02 pm
FDA
Biocon
Viatris
Avastin
biosimilars
drug manufacturing
AbbVie talks next steps as first Humira competitor makes it to market
Endpoints
Thu, 02/9/23 - 06:01 pm
AbbVie
Humira
biosimilars
Rick Gonzalez

Pages